* H
	* Coagulopathy\
		* Patients may be prothrombotic, anti-thrombotic, or fibrinolytic
		* Assays themselves (both coagulation profiles and point-of-care testing) may not correlate with the observed clinical effect
		* Treat if bleeding
		* Consider treating prior to procedures
		* Therapeutic options:
			* Vitamin K\
			Very reasonable, probably ineffective in the majority of patients.
			* PCC\
			Useful for factor replacement without volume load.
			* Fibrinogen\
			Target >1.5g/L. Dysfibrinogenaemia is likely in chronic disease.